However, select studies have implicated PTPRZ1 as a tumor suppressor [11,12] and low PTPRZ1 expression was found to be linked to a worse response to c-Met tyrosine kinase inhibitor in lung adenocarcinoma [13]. Here, PTPRZ1 is linked to lung adenocarcinoma.